Patents
Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
03/2010
03/11/2010WO2010027028A1 Agent for ameliorating impaired brain function
03/11/2010WO2010007090A3 Crystalline carbohydrate derivative
03/11/2010US20100062998 Prevention and/or Treatment of Neurodegenerative Disorders
03/11/2010US20100062991 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
03/11/2010US20100062055 Lipid-based nitric oxide donors
03/04/2010WO2009137193A3 Effect of carbohydrate concentration on sucralose extraction efficiency
02/2010
02/25/2010WO2009140345A3 Buffer rinsed sucralose crystals
02/25/2010US20100048738 Hybrid compounds based on polyol(s) and at least one other molecular entity, polymeric or non-polymeric, in particular of the polyorganosiloxane type, process for the preparation thereof, and applications thereof
02/25/2010US20100048483 Polymeric benzyl carbonate-derivatives
02/24/2010EP2155768A1 Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
02/24/2010CN101654467A Method for synthesizing sucralose
02/24/2010CN100591684C Crystallization method for trichlorosucrose
02/23/2010US7667012 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product; N-azidogalactosamine
02/18/2010WO2010018834A1 Method for releasing reducing glycan by ammonium salt
02/18/2010US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/16/2010US7662954 Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
02/16/2010US7662803 Such as polyoxyethylene, polyacrylamide homopolymers/copolymers with adrenergic agonists, narcotic and non-narcotic analgesics
02/16/2010US7662802 Halide-free glucosamine-acidic drug complexes
02/11/2010WO2010016587A1 Method for evaluating specific incorporation of d-glucose into cells
02/11/2010WO2009137192A3 Purification of sucralose containing feed streams for sucralose crystallization
02/11/2010US20100035834 Novel 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof
02/10/2010EP2150620A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexose derivatives, and new c-6 phosphorylated d-aldohexose derivatives
02/04/2010US20100029930 Stabilisation of Radiopharmaceutical Precursors
02/02/2010US7655639 Injection using a small bore needle a polysaccharide gel composition of dextran particles and hyaluronic acid which is collagen/ elastin-free; fibers; injecting an ingrowth of fibroblasts to form and aggregate collegen/elatin fibers in-situ; filling the spatial void; percutaneous closure
02/02/2010US7655251 Amphiphilicmonocatenary glycosylated hydrocarbon nitrones; oxidation resistance;free radical scavengers; neuroprotectants; cosmetic products for the skin, hair andnails; imunotherapy; antiinflammatory agents; Alzheimer's disease; Parkinson'sdisease; aging resistance; radiation injuries
01/2010
01/28/2010CA2731050A1 Methods for extracting and purifying sucralose intermediate
01/27/2010EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor
01/21/2010WO2010009197A1 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use
01/21/2010CA2730931A1 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use
01/21/2010CA2730395A1 Crystalline carbohydrate derivative
01/20/2010EP2144920A1 Novel compounds
01/20/2010EP1611893B1 Remedy for nerve damage
01/20/2010CN101628921A Preparation method of plant source D-glucosamine hydrochloride
01/19/2010US7649099 two step processes of producing isosorbide from sorbitol; first step in presence of a solid acid catalyst; second step in presence of a second catalyst selected from sulfuric acid, phosphoric acid, hydrochloric acid and p-toluenesulfonic acid; cost efficiency, environmentally friendly; therapeutic uses
01/14/2010US20100010210 Vaccine
01/14/2010US20100010187 Glucosamine materials
01/14/2010US20100008856 Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease
01/13/2010CN101627048A Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
01/12/2010US7645874 Cellulose oxidation by nitrogen dioxide in a perfluorinated tertiary amine solvent
01/07/2010US20100004196 Heparan sulfate proteoglycan composition and use thereof
01/07/2010US20100004160 Substituted fused heterocyclic c-glycosides
01/05/2010CA2175375C Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
12/2009
12/31/2009US20090324513 Process for Producing Chlorinated Sucrose
12/30/2009CN101613379A Preparation method of sucralose
12/29/2009US7638623 Galactoside inhibitors of galectins
12/29/2009CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
12/24/2009US20090318381 Halogenated alkyl di-and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment
12/17/2009US20090312283 Branched hyaluronic acid and method of manufacture
12/16/2009CN101605805A Improved sucralose production method
12/16/2009CN101602785A Method for quickly desalting and purifying selenizing oligosaccharide
12/09/2009CN101600725A Preparation of nucleosides ribofuranosyl pyrimidines
12/09/2009CN100567319C Crystallization method for sucrose trichloride
12/03/2009DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule
12/02/2009CN101591363A Preparation method of 2-C-acetonyl-2-deoxy-glucoside compounds
12/01/2009US7626016 Process for preparing sucrose-6-ester
11/2009
11/26/2009WO2009141486A1 Neoglycolipids, aggregates thereof with carbon nanotubes, method for obtaining same and use thereof
11/24/2009US7622576 Halide-free glucosamine base and method of preparation
11/19/2009WO2009139719A1 Novel synthesis of galactoside inhibitors
11/19/2009US20090286757 Antiviral composition
11/19/2009CA2724064A1 Novel synthesis of galactoside inhibitors
11/19/2009CA2723767A1 Novel uses of d-mannopyranose derivatives activating angiogenesis
11/18/2009CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009US7619076 Nod factor type compounds; result in a large increase in the number of nitrogen-fixing root nodules; 2-acetamido-4-O-{2-acetamido-4-O-[2-acetamido-2-deoxy-4-O-(2-deoxy-2-(N-3-(undec-4Z-enyloxy)benzoyl)amino- beta -D-glucopyranosyl)- beta -D-glucopyranosyl]-2-deoxy- beta -D-glucopyranosyl}-2-deoxy-D-gluco
11/12/2009US20090281296 Process for the production of conjugates from polysaccharides and polynucelotides
11/12/2009US20090281294 Process for production of compound labeled with radioactive fluorine
11/12/2009US20090281056 Cationized Hyaluronic Acid
11/10/2009US7615652 Two-stage dehydration of sugars
11/10/2009US7615528 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/05/2009WO2008045015A8 Imino and amino sugar purification
10/2009
10/22/2009WO2009101475A3 Use of glycosylceramides for enhancing the immune response to antigens
10/22/2009US20090264525 Fluorosurfactants
10/22/2009US20090263447 Crosslinked hyaluronic acid and process for the preparation thereof
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/14/2009EP1492802B1 Methods for buffer stabilized aqueous deacylation
10/14/2009CN101555263A D-glucose dithiocarbamate complex marked by TcO, preparation method and applications thereof
10/08/2009WO2009124116A1 Improved sucralose purification process
10/08/2009WO2009124113A1 Extraction of less polar impurities from sucralose containing aqueous feed streams
10/08/2009WO2003083074A9 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
10/08/2009US20090253651 Drug delivery system based on regioselectively amidated hyaluronic acid
10/08/2009US20090253117 Enzymatic substrates for multiple detection systems
10/07/2009EP2106403A2 Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
10/07/2009CN101550171A Technique for extracting D-glucosamine hydrochloride
10/07/2009CN101550170A Production technology hydrolytically separating glucosamine hydrochloride from mushrooms
10/07/2009CN101550169A Production technology separating glucosamine hydrochloride from citric acid sludge
10/06/2009US7598372 using a highly inexpensive natural polysaccharide having a mannose beta -1,4-bond as the starting material, a beta -1,4-glycoside bond of mannose is formed; preparing trisaccharide moiety of the reducing terminal utilizing galactomannan, guar gum and/or mannan derivatives
10/01/2009WO2009118532A1 Method for the production of sucralose
09/2009
09/29/2009US7595307 Polysaccharide derivatives and uses in induction of an immune response
09/24/2009WO2008059035A3 Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
09/24/2009US20090240046 Carboxylated glucosamine compounds for inhibiting the activation and expression of matrix metalloproteinase-9 in human fibrosarcoma cells and matrix metalloproteinase-9 inhibitors containing the same
09/24/2009US20090238875 Chitosan or Hyaluronic Acid-Poly(Ethylene Oxide)-and Chitosan-Hyaluronic Acid-Poly(Ethylene Oxide)-Based Hydrogel and Manufacturing Method Therefor
09/23/2009EP2102223A1 Improved sucralose production method
09/23/2009CN101541819A Methods for producing glucosamine from microbial biomass
09/22/2009US7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
09/17/2009WO2009087362A3 Method for the production of sucralose
09/17/2009US20090234111 Novel Lactosamine Derivatives
09/16/2009EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses
09/16/2009CN101535326A Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
09/16/2009CN101531688A Glucosamine sulfate calcium salt and preparation method thereof
09/16/2009CN101531687A Derivatizing reagent of polyhydroxy compound
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 37